Study of the efficacy, tolerability, and safety of 2 fixed-dose combination gels in the management of acne Vulgaris

Cutis

Volumn 84, Issue 4, 2009, Pages 223-229

  Zouboulis, Christos C ^a   Fischer, Tanja C ^b   Wohlrab, Johannes ^c   Barnard, Jo ^d   Alió, Alessandra B ^e  

^a DESSAU MEDICAL CENTER   (Germany)

^b Skin and Laser Center Potsdam   (Germany)

^c MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^d GLAXOSMITHKLINE   (United Kingdom)

^e Stiefel Laboratories Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77954056189     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Gollnick H, Cunliffe W, Berson D, et al; Global Alliance to Improve Outcomes in Acne. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49(suppl 1):S1-S37.
2. Tanghetti EA, Popp KF. A current review of topical benzoyl peroxide: new perspectives on formulation and utilization. Dermatol Clin. 2009;27:17-24.
3. Langner A, Chu A, Goulden V, et al. A randomized, single-blind comparison of topical clindamycin 1 benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris. Br J Dermatol. 2008;158:122-129.
4. Langner A, Sheehan-Dare R, Layton A. A randomized, single-blind comparison of topical clindamycin 1 benzoyl peroxide (Duac) and erythromycin 1 zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris. J Eur Acad Dermatol Venereol. 2007;21:311-319.
5. Tanghetti E, Kircik L, Wilson D, et al. Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne. J Drugs Dermatol. 2008;7:534-538.
6. Dhawan SS. Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris. Cutis. 2009;83:265-272.
7. Draelos ZD, Callender V, Young C, et al. The effect of vehicle formulation on acne medication tolerability. Cutis. 2008;82:281-284.
8. Fagundes DS, Fraser JM, Klauda HC. Difference in the irritation potential and cosmetic acceptability of two combination topical acne gels-combined results of two comparative studies. Today's Ther Trends. 2003;21:269-276.
9. Thiboutot DM, Weiss J, Bucko A, et al; Adapalene-BPO Study Group. Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study. J Am Acad Dermatol. 2007;57:791-799.
10. Gollnick HP, Draelos Z, Glenn MJ, et al; Adapalene-BPO Study Group. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients [published online ahead of print May 21, 2009]. Br J Dermatol. doi:10.1111/j.1365-2133.2009.09209.x.
11. Leyden JJ, Krochmal L, Yaroshinsky A. Two randomized, double-blind, controlled trials of 2219 subjects to compare the combination clindamycin/tretinoin hydrogel with each agent alone and vehicle for the treatment of acne vulgaris. J Am Acad Dermatol. 2006;54: 73-81.
12. Schlessinger J, Menter A, Gold M, et al; Ziana Study Group. Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris. J Drugs Dermatol. 2007;6:607-615.
13. Thiboutot D, Gollnick H, Bettoli V, et al; Global Alliance to Improve Outcomes in Acne. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol. 2009;60(suppl 5):S1-S50.
14. Koo J. How do you foster medication adherence for better acne vulgaris management? Skinmed. 2003;2:229-233.
15. Renzi C, Picardi A, Abeni D, et al. Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance. Arch Dermatol. 2002;138: 337-342.
16. Data on file. Maidenhead, UK: Stiefel, a GSK Company; 2009.